Back
Open Access

ESC-HF guidelines for management of MR and TR: the update and its clinical implications.

Session: Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines
Topic: Chronic Heart Failure
Speaker: Professor J. Bax (Leiden, NL) Professor R. von Bardeleben (Mainz, DE) Professor M. Boehm (Homburg, DE)
Sponsored by Edwards Lifesciences
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speakers

Professor Jeroen Bax

Leiden University Medical Center, Leiden (Netherlands (The))
86 presentations
11 followers

Professor Ralph Stephan von Bardeleben

University Medical Center of Mainz, Mainz (Germany)
76 presentations
11 followers

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
104 presentations
10 followers

4 more presentations in this session

Session opening​.

Speaker: Professor J. Bax (Leiden, NL)

Access
Video
Like
Thumbnail

Supporting HF treatment through transcatheter valve therapy​.

Speaker: Professor M. Boehm (Homburg, DE)

Access
Video
Like
Thumbnail

Successful treatment of MR and TR patients​ with differentiated transcatheter technologies.

Speaker: Professor R. von Bardeleben (Mainz, DE)

Access
Video
Like
Thumbnail

Session evaluation and key learnings​.

Speaker: Professor J. Bax (Leiden, NL)

Access
Video
Like
Thumbnail

Access the full session

Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines

Speakers: Professor J. Bax, Professor R. von Bardeleben, Professor M. Boehm, Professor J. Bax, Professor M. Boehm...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources